rxstatShortages › Sevelamer

Sevelamer (Renagel) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Sevelamer has no current shortage reported in Canada. No active reports are on file.

A phosphate binder used to control high blood phosphate levels in people with chronic kidney disease.

Products affected
0 / 1
Reports on file
1

Shortage history

2026

Shortage history (red bands = periods in shortage).

Reports by product

Resolved
RENAGEL
800MG · TABLET · SANOFI-AVENTIS CANADA INC
DIN 02244310 · ended Aug 29, 2025

What's happening

There are no active shortage reports for Sevelamer.

Sevelamer is classified under “ALL OTHER THERAPEUTIC PRODUCTS” (ATC V03AE).

Recent changes

Common questions

What is Sevelamer used for?

A phosphate binder used to control high blood phosphate levels in people with chronic kidney disease.

When will Sevelamer be back in stock in Canada?

Sevelamer has no active shortage; supply is normal per Health Canada reports.

Why is Sevelamer in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (all other therapeutic products)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.